APOLLOMICS INC-27 (APLMW)

0.02  +0 (+25.79%)

After market: 0.017 0 (-15%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

APOLLOMICS INC-27

NASDAQ:APLMW (11/29/2024, 12:46:41 PM)

After market: 0.017 0 (-15%)

0.02

+0 (+25.79%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-36.4%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap0
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

APLMW Daily chart

APLMW News

ChartMill News Image2 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

ChartMill News Image2 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Intrigued by the market activity in the middle of the day on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis.

ChartMill News Image2 days ago - ChartmillThe market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Let's have a look at the gap up and gap down stocks in today's session.

News Image8 days ago - Apollomics Inc.Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

The Company's class A ordinary shares will begin trading on a split-adjusted basis on November 25, 2024

News Image8 days ago - Apollomics Inc.Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

The Company's class A ordinary shares will begin trading on a split-adjusted basis on November 25, 2024...

News Image2 months ago - Apollomics Inc.Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

Vebreltinib is efficacious in both treatment naïve and previously treated patients with NSCLC with METex14 skipping, and regardless of co-occurring MET amplification

APLMW Twits

Here you can normally see the latest stock twits on APLMW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example